Guardion Health Sciences (GHSI) Financials

$3.22

$-0.05 (-1.53%)

As on 23-Jan-2025 09:30EDT

Market cap

$4 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	9.35	12.25	11.05	7.23	1.89	0.90
Cost of Revenue	5.33	6.85	6.53	4.12	1.95	0.34
Gross Profit	4.02	5.39	4.52	3.11	-0.06	0.56
Operating Expenses	7.89	9.73	11.84	13.59	8.45	9.50
Operating Profit (EBIT)	-3.87	-4.34	0.43	-10.48	-8.55	-8.93
Other Income	--	--	--	--	-0.01	--
Profit before Tax	-6.08	0.16	-14.92	-24.75	-8.57	-10.88
Provision for Tax	1.64	0.00	15.35	0.67	0.01	0.26
Profit after Tax (Net Income)	6.37	0.16	-30.28	-24.75	-8.58	-11.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-15.86	-24.75	-8.57	-10.88

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	13.75	8.15	13.17	22.30	8.52	12.03
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.63	2.45	4.51	0.00	0.27	0.43
Current Liabilities	0.92	1.32	4.01	1.16	1.07	0.41
Total Liabilities	16.22	11.92	21.69	23.46	9.86	12.88

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.01	0.03	0.05	11.39	0.77	1.01
Current Assets	15.29	11.88	21.64	12.07	9.09	11.87
Total Assets	16.22	11.92	21.69	23.46	9.86	12.88
Total Debt*	--	--	0.00	0.03	0.43	0.59
Net Current Assets	14.37	10.57	17.63	10.91	8.02	11.46

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-4.37	-7.45	-10.64	-8.01	-6.03
Cash Flow from Investing Activities	--	0.02	4.99	-31.01	-0.03	-0.17
Cash from Financing Activities	--	-5.19	14.27	37.23	5.45	16.65
Net Cash Inflow / Outflow	--	--	--	--	-2.60	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	4.96	0.12	-24.58	-0.02	-11.66	-37.09
Cash EPS ($)	--	0.37	-23.56	-0.02	-11.36	-35.00
Adjusted Book Value ($)	--	6.39	10.69	0.02	11.57	40.07
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.43	-6.04	-0.01	-10.89	-20.08
Free Cash Flow per Share ($)	--	-3.43	-6.05	-0.01	-10.94	-20.65

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	1.48	-170.60	-158.25	-79.55	-140.94
ROE (%)	58.23	1.48	-170.74	-160.61	-83.50	-146.37
ROA (%)	40.24	0.94	-134.13	-148.52	-75.46	-134.52
EBIT Margin (%)	-45.27	-32.18	-66.26	-146.70	-453.18	-1,176.16
Net Margin (%)	68.21	1.29	-274.01	-342.11	-457.01	-1,233.38
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-17.77	0.11	0.53	2.83	1.09	-0.04
EBIT Growth (%)	27.19	46.16	31.00	-23.89	19.36	-36.76
Net Profit Growth (%)	168.96	100.52	-22.36	-188.44	22.97	-43.38
EPS Growth (%)	165.80	1.01	-1,212.01	1.00	0.69	0.65
Book Value Growth (%)	87.40	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	43.09	-0.01	-31.94	-0.04	-0.01
Price / Book Value	0.32	0.84	0.01	35.44	0.04	0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.57	-0.11	1.72	-80.54	0.93	1.05
Close Price ($)	10.04	5.34	7.26	32.36	124.50	66.09
High Price ($)	10.75	8.33	37.13	420.00	222.00	1,200.00
Low Price ($)	5.01	4.66	6.50	32.00	49.50	49.50
Market Cap ($ Cr)	4.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	--	0.00	0.00	0.05	0.05
Short term debt to equity ratio	--	--	0.00	0.00	0.04	0.03
Current Ratio	16.67	9.01	5.39	10.41	8.47	28.93
Quick Ratio	16.59	6.98	4.62	10.10	8.11	28.17
Interest Coverage	-2.05	--	-0.48	-5,904.75	-1,177.88	-41.10

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	0.14	18.57	17.42	19.52	0.60	8.68
Asset Turnover	0.59	0.73	0.49	0.43	0.17	0.11
Receivable days	--	62.60	55.13	35.92	8.66	21.55
Inventory Days	--	154.45	97.53	33.34	65.29	357.92
Payable days	--	56.81	49.21	37.64	69.18	290.57
Cash Conversion Cycle	--	160.24	103.46	31.63	4.76	88.90

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.